Saturday, April 19, 2025
HomeTagsCritical care therapies

critical care therapies

Accord BioPharma Expands U.S. Biosimilar Portfolio with Acquisition of UDENYCA® from Coherus BioSciences

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, focused on the development of oncology, immunology, and critical care therapies, announced that Intas Pharmaceuticals...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics